History of Benzodiazepine Prescriptions and Risk of Dementia: Possible Bias Due to Prevalent Users and Covariate Measurement Timing in a Nested Case-Control Study

30Citations
Citations of this article
70Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Previous estimates of whether long-term exposure to benzodiazepines increases dementia risk are conflicting and are compromised by the difficulty of controlling for confounders and by reverse causation. We investigated how estimates for the association between benzodiazepine use and later dementia incidence varied based on study design choices, using a case-control study nested within the United Kingdom's Clinical Practice Research Datalink. A total of 40,770 dementia cases diagnosed between April 2006 and July 2015 were matched on age, sex, available data history, and deprivation to 283,933 control subjects. Benzodiazepines and Z-drug prescriptions were ascertained in a drug-exposure period 4-20 years before dementia diagnosis. Estimates varied with the inclusion of new or prevalent users, with the timing of covariate ascertainment, and with varying time between exposure and outcome. There was no association between any new prescription of benzodiazepines and dementia (adjusted odds ratio (OR) = 1.03, 95% confidence interval (CI): 1.00, 1.07), whereas an inverse association was observed among prevalent users (adjusted OR = 0.91, 95% CI: 0.87, 0.95), although this was likely induced by unintentional adjustment for colliders. By considering the choice of confounders and timing of exposure and covariate measurement, our findings overall are consistent with no causal effect of benzodiazepines or Z-drugs on dementia incidence.

References Powered by Scopus

Multiple imputation using chained equations: Issues and guidance for practice

6567Citations
N/AReaders
Get full text

Dementia prevention, intervention, and care

4365Citations
N/AReaders
Get full text

Equivalence of the mediation, confounding and suppression effect

2974Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Dementia prevention, intervention, and care: 2020 report of the Lancet Commission

6302Citations
N/AReaders
Get full text

Benzodiazepines Remain Important Therapeutic Options in Psychiatric Practice

78Citations
N/AReaders
Get full text

Anticholinergic and benzodiazepine medication use and risk of incident dementia: A UK cohort study

48Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Richardson, K., Mattishent, K., Loke, Y. K., Steel, N., Fox, C., Grossi, C. M., … Savva, G. M. (2019). History of Benzodiazepine Prescriptions and Risk of Dementia: Possible Bias Due to Prevalent Users and Covariate Measurement Timing in a Nested Case-Control Study. American Journal of Epidemiology, 188(7), 1228–1236. https://doi.org/10.1093/aje/kwz073

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 19

56%

Researcher 9

26%

Professor / Associate Prof. 4

12%

Lecturer / Post doc 2

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 12

44%

Pharmacology, Toxicology and Pharmaceut... 6

22%

Neuroscience 6

22%

Psychology 3

11%

Article Metrics

Tooltip
Mentions
News Mentions: 1
Social Media
Shares, Likes & Comments: 1

Save time finding and organizing research with Mendeley

Sign up for free